Mithra Pharmaceuticals SA

OTCPK:MITP.F Stock Report

Market Cap: US$236.6m

Mithra Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MITP.F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,869,7533.47%
VC/PE Firms2,975,9285.52%
Institutions7,288,86613.5%
Individual Insiders14,133,59726.2%
General Public27,602,21351.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.3%.

Top Shareholders

Top 25 shareholders own 49.76% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20.8%
Francois Fornieri
11,204,201US$49.2m0%no data
9.42%
Noshaq S.A.
5,074,870US$22.3m0%100.0%
5.52%
Alychlo NV
2,975,928US$13.1m0%3.95%
3.16%
Bart Versluys
1,700,598US$7.5m0%no data
2.19%
Ogesip Invest Sa
1,180,098US$5.2m0%no data
2.17%
Marc Armand Alice Andre Coucke
1,170,120US$5.1m0%no data
1.46%
The Vanguard Group, Inc.
788,503US$3.5m0%no data
1.28%
Selva Luxembourg S.A.
689,655US$3.0m0%no data
0.78%
BNPP Asset Management Holding
418,147US$1.8m0%no data
0.68%
Norges Bank Investment Management
368,971US$1.6m0%no data
0.54%
BlackRock, Inc.
292,687US$1.3m-0.24%no data
0.52%
Janus Henderson Group plc
280,164US$1.2m0%no data
0.41%
AXA Investment Managers S.A.
221,000US$970.8k0%no data
0.21%
BNPP Asset Management France
113,262US$497.5k0%no data
0.2%
Fondbolaget Fondita AB
106,600US$468.2k0%0.07%
0.088%
Charles Schwab Investment Management, Inc.
47,264US$207.6k-1.29%no data
0.07%
Valerie Gordenne
37,500US$164.7k0%no data
0.05%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
27,091US$119.0k0%no data
0.04%
State Street Global Advisors, Inc.
21,377US$93.9k0.45%no data
0.038%
Jean-Michel Foidart
20,370US$89.5k0%no data
0.03%
Candriam Luxembourg S.A.
16,298US$71.6k0%no data
0.028%
Credit Suisse Asset Management (Switzerland)
15,226US$66.9k0%no data
0.025%
Capfi Delen Asset Management NV
13,590US$59.7k0%no data
0.022%
Deutsche Asset & Wealth Management
11,901US$52.3k0%no data
0.02%
Dimensional Fund Advisors LP
10,687US$46.9k143%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/12/05 05:33
End of Day Share Price 2022/09/07 00:00
Earnings2022/06/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mithra Pharmaceuticals SA is covered by 3 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Beatrice AllenBerenberg
Maxime StranartING Groep NV
Thomas LandemaineKepler Cheuvreux